文献速递肺结节与肺癌

基于转移淋巴结数量与比例两种新淋巴结分类方案在非小细胞肺癌中的比较

Comparison of Two Proposed Changes to the Current Nodal Classification for Non--small Cell Lung Cancer Based on the Number and Ratio of Metastatic Lymph Nodes.
PubMed 文献 · Chest · 2021-05-21

该研究基于SEER数据库2004-2016年2162例N1或N2非小细胞肺癌患者,比较了现行N分期与结合转移淋巴结数量(N-#number)或比例(N-#ratio)的两种新分类方案。结果显示N-#number分类较N-#ratio分类及现行N分期提供更准确的预后分层,生存曲线在各分类间差异清晰。

要点

  • N-#number分类在全部肿瘤大小亚组中均显示LCSS从N-#number-1至N-#number-2b显著恶化趋势。
  • N-#ratio分类各对间差异仅在肿瘤3-7cm时显著。
  • 三种淋巴结分类均为独立预后指标,但N-#number分类预后分层最准确。

核心结论

  • N-#number分类可能优于N-#ratio分类及现行N分期,作为N1或N2非小细胞肺癌的预后决定因素。

研究设计与样本

  • 回顾性队列研究,从SEER数据库(2004-2016)识别2162例N1或N2非小细胞肺癌患者。
  • 将患者分为三个N-#number类别(N-#number-1、N-#number-2a、N-#number-2b)和三个N-#ratio类别(N-#ratio-1、N-#ratio-2a、N-#ratio-2b)。
  • 采用Kaplan-Meier法比较肺癌特异性生存(LCSS),Cox比例风险回归评估各分类与LCSS的关联。

主要发现

  • 生存曲线显示N-#number和N-#ratio各对类别间均有明显差异。
  • 在所有肿瘤大小类别(≤3cm、3-5cm、5-7cm、>7cm)中均观察到LCSS从N-#number-1至N-#number-2b显著恶化趋势。
  • N-#ratio各类别间差异仅在肿瘤3-7cm时显著。
  • 三种淋巴结分类均为独立预后指标,但N-#number分类较N-#ratio分类和现行N分期提供更准确的预后分层。

关键数值与推荐

  • N-#number分类包含三个类别:N-#number-1、N-#number-2a、N-#number-2b。
  • N-#ratio分类包含三个类别:N-#ratio-1、N-#ratio-2a、N-#ratio-2b。
  • 肿瘤大小亚组:≤3cm、3-5cm、5-7cm、>7cm。

临床怎么用

  • 在N1或N2非小细胞肺癌预后评估中,可考虑结合转移淋巴结数量(N-#number)进行更精细分层。
  • N-#number分类可能较现行N分期提供更准确的预后信息,但需外部验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The current nodal classification is unsatisfactory in distinguishing the prognostically heterogeneous N1 or N2 non-small cell lung cancer (NSCLC). RESEARCH QUESTION: Is the combination of the current N category and the number of metastatic lymph nodes (N-#number) or the combination of the current N category and the ratio of the number of positive to resected lymph nodes (N-#ratio) better than the current N category alone? STUDY DESIGN AND METHODS: We identified 2,162 patients with N1 or N2 NSCLC from the Surveillance, Epidemiology, and End Results database (2004-2016). We classified these patients into three N-#number categories (N-#number-1, N-#number-2a, N-#number-2b) and three N-#ratio categories (N-#ratio-1, N-#ratio-2a, N-#ratio-2b). Lung cancer-specific survival (LCSS) were compared using the Kaplan-Meier method. The prognostic significance of the new nodal classifications was validated across each tumor size category (≤3 cm, 3-5 cm, 5-7cm, >7 cm). Cox proportional hazards regression was used to evaluate the association between each nodal classification and LCSS. RESULTS: The survival curves showed clear differences between each pair of N-#number and N-#ratio categories. A significant tendency toward the deterioration of LCSS from N-#number-1 to N-#number-2b was observed in all tumor size categories. However, the differences between each pair of N-#ratio categories were significant only in tumors from 3 to 7 cm. Although all three nodal classifications were independent prognostic indicators, the N-#number classification provided more accurate prognostic stratifications compared with the N-#ratio classification and the current nodal classification. INTERPRETATION: The N-#number classification followed by the N-#ratio classification might be better prognostic determinants than the current nodal classification in prognostically heterogeneous N1 or N2 NSCLC.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Li F, Yuan L, Zhao Y, et al. Comparison of Two Proposed Changes to the Current Nodal Classification for Non--small Cell Lung Cancer Based on the Number and Ratio of Metastatic Lymph Nodes. Chest. 2021. PMID: 34029562. doi:10.1016/j.chest.2021.05.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。